What indirect IDEXX (IDXX) holdings related to Michael Lane are disclosed?

The Form 4 reports 592 IDEXX common shares held indirectly in an IRA owned by Lane’s spouse. A footnote states he disclaims beneficial ownership of those shares, except to the extent of any pecuniary interest he may have in the account.

IDXX Form 4 reports multiple insider transactions

Lane Michael reported multiple insider transaction types in a Form 4 filing for IDXX.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Lane Michael reported multiple insider transaction types in a Form 4 filing for IDXX. The filing lists transactions totaling 10,810 shares at a weighted average price of $629.35 per share. Following the reported transactions, holdings were 1,101 shares.

Insider Trade Summary

1,092 shares exercised/converted

Exercise 14 txns

Insider Lane Michael

Role Executive Vice President

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	367	$0.00	$0.00
Exercise	Restricted Stock Unit	204	$0.00	$0.00
Exercise	Restricted Stock Unit	220	$0.00	$0.00
Exercise	Restricted Stock Unit	301	$0.00	$0.00
Exercise	Common Stock	204	$0.00	$0.00
Exercise	Common Stock	220	$0.00	$0.00
Exercise	Common Stock	301	$0.00	$0.00
Exercise	Common Stock	367	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	221	$629.35	$139K
Grant/Award	Non-Qualified Stock Option (right-to-buy)	5,361	$0.00	$0.00
Grant/Award	Incentive Stock Option (right-to-buy)	162	$0.00	$0.00
Grant/Award	Restricted Stock Unit	1,262	$0.00	$0.00
Grant/Award	Restricted Stock Unit	1,620	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right-to-buy) — 5,361 contracts (Direct); Incentive Stock Option (right-to-buy) — 162 contracts (Direct); Restricted Stock Unit — 4,805 contracts (Direct); Common Stock — 8,023.944 shares (Direct); Common Stock — 592 shares (Indirect, by spouse)

Footnotes (13)

F1. Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on September 30, 2025 and December 31, 2025. There are a total of 252.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares.
F2. Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's termination of employment with the Issuer.
F3. Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
F4. Includes 367 vested but deferred RSUs.
F5. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F6. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
F7. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
F8. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027.
F9. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in three annual installments, beginning February 14, 2027.
F10. Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.
F11. Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023.
F12. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
F13. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did IDEXX (IDXX) executive Michael Lane report?

Michael Lane reported equity compensation activity, including new option and RSU grants plus RSU vesting into common stock. The filing also shows a small share disposition used to cover tax obligations tied to these awards, rather than an open-market sale.

How many stock options did Michael Lane receive in this IDEXX (IDXX) Form 4?

Lane received 5,361 non-qualified stock options and 162 incentive stock options. Footnotes state these options become exercisable in scheduled installments starting February 14, 2027 and February 14, 2030, reflecting long-term, time-based vesting rather than immediately exercisable options.

What restricted stock unit (RSU) grants were disclosed for IDEXX (IDXX) executive Michael Lane?

The filing shows new RSU grants of 1,262 and 1,620 units. Footnotes explain these RSUs will vest in annual installments beginning February 14, 2027 and be deferred into the company’s Deferred Compensation Plan, each ultimately representing one share of IDEXX common stock.

Did Michael Lane sell IDEXX (IDXX) shares in the open market?

The Form 4 shows a 221‑share disposition coded “F,” meaning shares were withheld to pay taxes at a price of $629.35. This represents a tax-withholding transaction, not a discretionary open-market sale of IDEXX common stock by the executive.

How many IDEXX (IDXX) common shares does Michael Lane now hold directly?

After the reported RSU conversions and tax-withholding disposition, Michael Lane directly holds 8,023.944 shares of IDEXX common stock. This figure reflects only his direct ownership and excludes indirect shares held in his spouse’s IRA account.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/17/2026 - 07:30 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lane Michael

(Last)

(First)

(Middle)

ONE IDEXX DRIVE

(Street)

WESTBROOK

04092

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/14/2026		M		204	A	$0	7,356.944⁽¹⁾	D
Common Stock	02/14/2026		M		220	A	$0	7,576.944	D
Common Stock	02/14/2026		M		301	A	$0	7,877.944	D
Common Stock	02/14/2026		M		367⁽²⁾	A	$0	8,244.944	D
Common Stock	02/14/2026		F		221	D	$629.35⁽³⁾	8,023.944⁽⁴⁾	D
Common Stock								592⁽⁵⁾	I	by spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (right-to-buy)	$617.2	02/12/2026		A		5,361		⁽⁶⁾	02/11/2036	Common Stock	5,361	$0	5,361	D
Incentive Stock Option (right-to-buy)	$617.2	02/12/2026		A		162		⁽⁷⁾	02/11/2036	Common Stock	162	$0	162	D
Restricted Stock Unit	⁽⁸⁾	02/12/2026		A		1,262		⁽⁸⁾	⁽⁸⁾	Common Stock	1,262	$0	1,262	D
Restricted Stock Unit	⁽⁹⁾	02/12/2026		A		1,620		⁽⁹⁾	⁽⁹⁾	Common Stock	1,620	$0	1,620	D
Restricted Stock Unit	⁽¹⁰⁾	02/14/2026		M			367	⁽¹⁰⁾	⁽¹⁰⁾	Common Stock	367	$0	1,101	D
Restricted Stock Unit	⁽¹¹⁾	02/14/2026		M			204	⁽¹¹⁾	⁽¹¹⁾	Common Stock	204	$0	0	D
Restricted Stock Unit	⁽¹²⁾	02/14/2026		M			220	⁽¹²⁾	⁽¹²⁾	Common Stock	220	$0	220	D
Restricted Stock Unit	⁽¹³⁾	02/14/2026		M			301	⁽¹³⁾	⁽¹³⁾	Common Stock	301	$0	602	D

Explanation of Responses:

1. Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on September 30, 2025 and December 31, 2025. There are a total of 252.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares.

2. Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's termination of employment with the Issuer.

3. Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.

4. Includes 367 vested but deferred RSUs.

5. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.

6. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.

7. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.

8. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027.

9. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in three annual installments, beginning February 14, 2027.

10. Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.

11. Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023.

12. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.

13. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.

Remarks:

	/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR